Physician profile
John R Vender
NPI 1174634174
$688.07
in general payments reported to CMS, 2019-2025
16 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $38.63 · 2021: $28.73 · 2022: $82.32 · 2023: $157 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $126.16 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $100.46 | 2021-2025 | Plasmablade(Tm), Aquamantys(Tm), Kyphon Express II Kyphopak Tray |
| Leica Microsystems INC. | $91.16 | 2025 | |
| Zap Surgical Systems, INC. | $63.25 | 2025 | Zap-X Radiosurgery System, Zap-X Treatment Delivery Software, Zap-X Treatment Planning Software |
| Aesculap, INC. | $50.76 | 2019-2020 | |
| Depuy Synthes Sales INC. | $38.11 | 2019 | |
| Lemaitre Vascular, INC. | $34.69 | 2019 | |
| Integra Lifesciences Corporation | $32.77 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $30.14 | 2019-2022 | |
| Baxter Healthcare | $24.15 | 2023 | Floseal |
| Kuros Biosciences USA, INC | $21.89 | 2023 | |
| Abbvie INC. | $18.31 | 2023 | Qulipta |
| Globus Medical, INC. | $15.07 | 2025 | Senza |
| Nevro Corp. | $14.40 | 2019 | |
| Flowonix Medical Incorporated | $14.16 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $12.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Vender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.